Design, Synthesis, and Antitumor Activity Evaluation of 2-Phenylthiazole-5-Carboxylic Acid Derivatives Targeting Transactivation Response RNA-Binding Protein 2

emerges as a promising HCC treatment candidate with potent TRBP inhibition and favorable drug-like properties.